Post-approval safety issues with innovative drugs: a European cohort study.
about
Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests.Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test batteryDesign principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells.Postmarketing Safety Events Relating to New Drugs Approved in Brazil Between 2003 and 2013: A Retrospective Cohort Study.A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee.Registries supporting new drug applications.Analysis of Safety-Related Regulatory Actions for New Drugs in Japan by Nature of Identified Risks.Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?
P2860
Q29248402-8B8F71D7-1D8E-4A12-841F-78103F9445FAQ35137761-295DAEE6-B7A7-4095-A631-280DC1FD5007Q37644135-DE6C08C3-D357-47BB-857C-41FF459A811BQ40604485-18D46A48-31B7-4A50-9ED8-898343CEF3B1Q46897284-649C6DC4-29D4-4ADA-A80E-FD58F761A95FQ47102430-D914A6DD-873F-4585-9BA3-CCE477512338Q47161890-BACD3983-8BE4-4446-89A0-CD3B9D24A76BQ48347862-9B6CCD86-D957-45C3-ADC2-B618F6BA75C4
P2860
Post-approval safety issues with innovative drugs: a European cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Post-approval safety issues with innovative drugs: a European cohort study.
@en
Post-approval safety issues with innovative drugs: a European cohort study.
@nl
type
label
Post-approval safety issues with innovative drugs: a European cohort study.
@en
Post-approval safety issues with innovative drugs: a European cohort study.
@nl
prefLabel
Post-approval safety issues with innovative drugs: a European cohort study.
@en
Post-approval safety issues with innovative drugs: a European cohort study.
@nl
P2093
P2860
P50
P1433
P1476
Post-approval safety issues with innovative drugs: a European cohort study.
@en
P2093
Arna H Arnardottir
Flora M Haaijer-Ruskamp
Patrick J Vrijlandt
Petra Denig
Pieter A de Graeff
Sabine M J M Straus
P2860
P2888
P304
P356
10.1007/S40264-013-0094-Y
P577
2013-11-01T00:00:00Z
P6179
1001337177